Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Mediators Inflamm ; 2006(5): 72620, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17392577

RESUMEN

UNLABELLED: Exhaled nitric oxide (eNO) detects airway inflammation. Hyperbaric oxygen therapy (HBOT) is used for tissue hypoxia, but can cause lung damage. We measured eNO following inhalation of oxygen at different tensions and pressures. METHODS: Part 1, eNO was measured before and after HBOT. Part 2, normal subjects breathed 40% oxygen. RESULTS: Baseline eNO levels in patients prior to HBOT exposure were significantly higher than in normal subjects (P < .05). After HBOT, eNO significantly decreased in patients (15.4 +/- 2.0 versus 4.4 +/- 0.5 ppb, P < .001), but not in normal subjects, after either 100% O2 at increased pressure or 40% oxygen, 1 ATA. In an in vitro study, nitrate/nitrite release decreased after 90 minutes HBOT in airway epithelial (A549) cells. CONCLUSION: HBO exposure causes a fall in eNO. Inducible nitric oxide synthase (iNOS) may cause elevated eNO in patients secondary to inflammation, and inhibition of iNOS may be the mechanism of the reduction of eNO seen with HBOT.


Asunto(s)
Espiración , Oxigenoterapia Hiperbárica , Mediadores de Inflamación/metabolismo , Óxido Nítrico/metabolismo , Biomarcadores/metabolismo , Pruebas Respiratorias , Estudios de Casos y Controles , Línea Celular , Femenino , Humanos , Oxigenoterapia Hiperbárica/efectos adversos , Pulmón/metabolismo , Lesión Pulmonar , Masculino , Óxido Nítrico Sintasa de Tipo II/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo II/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA